ENH say which papers I stole
This commit is contained in:
parent
81c03f4199
commit
a5a9804f97
|
@ -29,6 +29,14 @@
|
|||
urlcolor=black,
|
||||
}
|
||||
|
||||
\newcommand{\dmspaper}{Dwarshuis et al. Functionalized microcarriers improve T
|
||||
cell manufacturing by facilitating migratory memory T cell production and
|
||||
increasing CD4/CD8 ratio.~2019.~biorxiv.~https://doi.org/10.1101/646760}
|
||||
|
||||
\newcommand{\modelpaper}{Odeh-Couvertier et al. Predicting T Cell Quality During
|
||||
Manufacturing Through an Artificial Intelligence-based Integrative Multi-Omics
|
||||
Analytical Platform.~2019.~biorxiv.~https://doi.org/10.1101/2021.05.05.442854}
|
||||
|
||||
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|
||||
% my attempt to make MATLAB code look pretty
|
||||
|
||||
|
@ -1297,7 +1305,7 @@ system to state-of-the-art T cell activation technologies for both expansion
|
|||
potential and memory cell formation. The governing hypothesis was that
|
||||
microcarriers functionalized with \acd{3} and \acd{28} \glspl{mab} will
|
||||
provide superior expansion and memory phenotype compared to state-of-the-art
|
||||
bead-based T cell expansion technology.
|
||||
bead-based T cell expansion technology\footnote{adapted from \dmspaper{}}.
|
||||
|
||||
\section{Methods}
|
||||
|
||||
|
@ -1778,8 +1786,7 @@ validity using residual plots (to assess constant variance and independence
|
|||
assumptions), QQplots and Shapiro-Wilk normality test (to assess normality
|
||||
assumptions), Box-Cox plots (to assess need for power transformations), and
|
||||
lack-of-fit tests where replicates were present (to assess model fit in the
|
||||
context of pure error). Statistical significance was evaluated at $\upalpha$ =
|
||||
0.05.
|
||||
context of pure error). Significance was evaluated at $\upalpha$ = 0.05.
|
||||
|
||||
\subsection{Flow Cytometry}\label{sec:flow_cytometry}
|
||||
|
||||
|
@ -2745,7 +2752,7 @@ predict the outcome of the cultures. We should stress that the specific
|
|||
universal, as this was not performed with equipment that would normally be used
|
||||
at scale. However, the process outlined here is one that can easily be adaptable
|
||||
to any system, and the specific findings themselves offer interesting insights
|
||||
that warrant further study.
|
||||
that warrant further study\footnote{adapted from \modelpaper{}}.
|
||||
|
||||
\section{Methods}
|
||||
|
||||
|
@ -4061,13 +4068,13 @@ the early work with \il{15} in mice\cite{Lodolce1998}.
|
|||
|
||||
The purpose of this aim was to verify that \gls{car} T cells produced using the
|
||||
\gls{dms} system will show potent anti-tumor properties in a complex \invivo{}
|
||||
system compared to state-of-the-art bead technology. We hypothesized that due to
|
||||
the increased \ptmem{} and \pth{} phenotypes as shown in \cref{aim1}, that
|
||||
\gls{dms}-expanded T cells would show longer survival and lower tumor burden
|
||||
than those expanded with beads. We explored the effect of dosing at different
|
||||
levels and the effect of harvesting T cells at early timepoints in the culture,
|
||||
which has been shown to produce lower-differentiated T cells with higher
|
||||
potency\cite{Ghassemi2018}.
|
||||
system compared to state-of-the-art bead technology\footnote{adapted from
|
||||
\dmspaper{}}. We hypothesized that due to the increased \ptmem{} and \pth{}
|
||||
phenotypes as shown in \cref{aim1}, that \gls{dms}-expanded T cells would show
|
||||
longer survival and lower tumor burden than those expanded with beads. We
|
||||
explored the effect of dosing at different levels and the effect of harvesting T
|
||||
cells at early timepoints in the culture, which has been shown to produce
|
||||
lower-differentiated T cells with higher potency\cite{Ghassemi2018}.
|
||||
|
||||
\section{Methods}
|
||||
|
||||
|
|
Loading…
Reference in New Issue